The RNA Analysis Transcriptomics Market is valued at USD 7.4 Bn in 2026.
The RNA Analysis Transcriptomics Market is projected to grow at a CAGR of 12% by 2033.
The market growth is driven by rising adoption of personalised medicine, increasing cancer cases, and growing investment in R&D.
North America is a dominating region for the RNA analysis transcriptomics market.
Agilent Technologies Inc., Bio-Rad Laboratories, F. Hoffmann-La Roche, Illumina Inc., and Thermo Fisher Scientific are some leading industry players in the RNA analysis transcriptomics market.